@article{e024c85298424583b3b94791a38db71e,
title = "Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib",
abstract = "Nonmelanoma skin cancers (NMSCs) in ruxolitinib-treated patients with myeloproliferative neoplasms behave aggressively, with adverse features and high recurrence. In our cohort, mortality from metastatic NMSC exceeded that from myelofibrosis. Vigilant skin assessment, counseling on NMSC risks, and prospective ruxolitinib-NMSC studies are crucial.",
keywords = "Humans, Prospective Studies, Myeloproliferative Disorders/drug therapy, Nitriles, Skin Neoplasms/drug therapy, Pyrazoles, Pyrimidines",
author = "Alex Rampotas and Luke Carter-Brzezinski and Somervaille, {Tim C P} and James Forryan and Fotios Panitsas and Claire Harrison and Ruth Witherall and Innes, {Andrew J} and Louise Wallis and Butt, {Naumann M} and Bethan Psaila and Mead, {Adam J} and Matthew Carter and Godfrey, {Anna L} and Heather Laing and Mamta Garg and Sebastian Francis and Joanne Ewing and Teh, {Chun Huat} and Cowen, {Hannah Bibi} and Peter Dyer and Conall McConville and Frances Wadelin and Ali Sahra and Andrew McGregor and Elizabeth Kulakov and McLornan, {Donal P} and Jonathan Lambert",
note = "{\textcopyright} 2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.",
year = "2024",
month = jan,
day = "11",
doi = "10.1182/blood.2023022345",
language = "English",
volume = "143",
pages = "178--182",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "2",
}
